Drugs for metabolic conditions and prostate cancer death in men on GnRH agonists.

OBJECTIVE To evaluate whether drugs for metabolic conditions influence prostate cancer-specific mortality in men starting gonadotrophin-releasing hormone (GnRH) agonists, as it is unclear whether metabolic syndrome and its related drugs is affecting treatment response in men with prostate cancer on GnRH agonists. PATIENTS AND METHODS We selected all men… (More)